PH12015500452B1 - A method for selection of agents influencing intestinal motility disorders and pain - Google Patents

A method for selection of agents influencing intestinal motility disorders and pain

Info

Publication number
PH12015500452B1
PH12015500452B1 PH1/2015/500452A PH12015500452A PH12015500452B1 PH 12015500452 B1 PH12015500452 B1 PH 12015500452B1 PH 12015500452 A PH12015500452 A PH 12015500452A PH 12015500452 B1 PH12015500452 B1 PH 12015500452B1
Authority
PH
Philippines
Prior art keywords
intestinal motility
selection
motility disorders
treatment
agent
Prior art date
Application number
PH1/2015/500452A
Other languages
English (en)
Other versions
PH12015500452A1 (en
Inventor
John Bienenstock
Eamonn Connolly
Wolfgang Kunze
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49115523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12015500452(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of PH12015500452A1 publication Critical patent/PH12015500452A1/en
Publication of PH12015500452B1 publication Critical patent/PH12015500452B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/10—Segmentation; Edge detection
    • G06T7/13—Edge detection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30092—Stomach; Gastric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Quality & Reliability (AREA)
  • Toxicology (AREA)
  • Radiology & Medical Imaging (AREA)
PH1/2015/500452A 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain PH12015500452B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261696277P 2012-09-03 2012-09-03
PCT/EP2013/068202 WO2014033330A1 (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain

Publications (2)

Publication Number Publication Date
PH12015500452A1 PH12015500452A1 (en) 2015-04-20
PH12015500452B1 true PH12015500452B1 (en) 2023-01-20

Family

ID=49115523

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2015/500452A PH12015500452B1 (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain

Country Status (27)

Country Link
US (5) US9555065B2 (enExample)
EP (2) EP3369808A1 (enExample)
JP (3) JP6259458B2 (enExample)
KR (1) KR102293438B1 (enExample)
CN (4) CN108904545A (enExample)
AU (1) AU2013308299B2 (enExample)
CA (2) CA3268968A1 (enExample)
CL (2) CL2015000490A1 (enExample)
CO (1) CO7350654A2 (enExample)
DK (1) DK2893045T3 (enExample)
ES (1) ES2681974T3 (enExample)
GE (1) GEP201706775B (enExample)
HK (1) HK1258778A1 (enExample)
HR (1) HRP20181033T1 (enExample)
IL (2) IL237397B (enExample)
IN (1) IN2015DN01572A (enExample)
LT (1) LT2893045T (enExample)
MX (2) MX362495B (enExample)
MY (2) MY195532A (enExample)
NZ (1) NZ705358A (enExample)
PH (1) PH12015500452B1 (enExample)
RU (1) RU2701348C2 (enExample)
SG (3) SG10201608055XA (enExample)
SI (1) SI2893045T1 (enExample)
UA (2) UA118339C2 (enExample)
WO (1) WO2014033330A1 (enExample)
ZA (1) ZA201501472B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013002667B1 (pt) 2010-08-04 2020-02-04 Thomas Julius Borody composições para transplante da flora intestinal e métodos para fazê-las e usá-las e dispositivos para administrá-las
CN108094541A (zh) * 2018-01-11 2018-06-01 黑龙江完达山林海液奶有限公司 一种具有保健益生功能的风味发酵乳及其制备方法
CN117487686A (zh) * 2018-07-24 2024-02-02 生命大地女神有限公司 选择和使用褪黑素支持细菌以减少婴儿绞痛
WO2020247568A1 (en) * 2019-06-05 2020-12-10 Avl Powertrain Engineering, Inc. Vehicle axle assembly
EP3980285A1 (en) 2019-06-05 2022-04-13 AVL Powertrain Engineering, Inc. Vehicle frame assembly and power supply tray
US12263752B2 (en) 2019-06-05 2025-04-01 Avl Mobility Technologies, Inc. Vehicle frame and power supply assembly and related systems and methods
CN110186922B (zh) * 2019-06-25 2021-07-23 西安交通大学医学院第一附属医院 一种监测结肠移行性复合运动的实验装置及方法
US11843097B2 (en) 2019-09-10 2023-12-12 Avl Powertrain Engineering, Inc. Power supply control systems and methods
CN112710823B (zh) * 2020-12-17 2024-03-29 中国科学院深圳先进技术研究院 一种肠移行性复合运动的离体检测系统及其应用
CN114342878B (zh) * 2022-01-10 2022-09-30 南京鼓楼医院 一种慢传输型便秘动物模型的建立方法
CN117384804A (zh) * 2023-12-12 2024-01-12 北京三元食品股份有限公司 格氏乳杆菌b1-26及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438989A (en) * 1990-08-10 1995-08-08 Hochman; Darryl Solid tumor, cortical function, and nerve tissue imaging methods and device
TR200100361T2 (tr) * 1998-08-21 2001-06-21 Novartis Ag Yeni oral formülasyon
CZ200213A3 (cs) * 1999-07-06 2002-08-14 Enpharma L. P. Prostředky k regulaci motility zaľívací soustavy a přijímání potravy
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
CN1663573B (zh) * 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
US20090233888A1 (en) * 2005-03-23 2009-09-17 Usc Stevens, University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
JP5036020B2 (ja) * 2005-11-30 2012-09-26 雪印メグミルク株式会社 腎周囲脂肪蓄積抑制剤
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
JP5019563B2 (ja) * 2006-06-16 2012-09-05 旭化成ケミカルズ株式会社 腸内細菌賦活剤
US9254275B2 (en) * 2007-09-17 2016-02-09 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
SG177541A1 (en) * 2009-07-31 2012-02-28 Nestec Sa Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
US20110110905A1 (en) * 2009-11-06 2011-05-12 Ritchie Jennifer A Infant Colic Supplement
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US20120034198A1 (en) * 2010-08-04 2012-02-09 Microbios, Inc. Carriers for storage and delivery of biologics
CN102304489B (zh) * 2011-09-23 2013-06-12 北京龙科方舟生物工程技术有限公司 一株罗伊氏乳杆菌及其应用

Also Published As

Publication number Publication date
AU2013308299A1 (en) 2015-03-26
EP3369808A1 (en) 2018-09-05
JP6259458B2 (ja) 2018-01-10
CN108904545A (zh) 2018-11-30
SG11201501297TA (en) 2015-03-30
PH12015500452A1 (en) 2015-04-20
SG10201608055XA (en) 2016-11-29
RU2015112102A (ru) 2016-10-20
MY195532A (en) 2023-01-31
US20170114422A1 (en) 2017-04-27
HK1258774A1 (zh) 2019-11-22
CN108753645A (zh) 2018-11-06
US20220306984A1 (en) 2022-09-29
MX362495B (es) 2019-01-21
AU2013308299B2 (en) 2019-04-18
IN2015DN01572A (enExample) 2015-07-03
CO7350654A2 (es) 2015-08-10
HK1211848A1 (en) 2016-06-03
GEP201706775B (en) 2017-11-27
RU2701348C2 (ru) 2019-09-26
JP2018090616A (ja) 2018-06-14
NZ705358A (en) 2018-09-28
JP2018029588A (ja) 2018-03-01
HRP20181033T1 (hr) 2018-08-24
US20190112676A1 (en) 2019-04-18
MY182358A (en) 2021-01-20
CA3268968A1 (en) 2025-11-29
KR20150048201A (ko) 2015-05-06
HK1258778A1 (zh) 2019-11-22
IL259652B (en) 2020-03-31
UA126374C2 (uk) 2022-09-28
CA2883440A1 (en) 2014-03-06
CN108753645B (zh) 2019-10-22
CN104918640A (zh) 2015-09-16
JP2015529329A (ja) 2015-10-05
ES2681974T3 (es) 2018-09-17
KR102293438B1 (ko) 2021-08-25
CL2015000490A1 (es) 2015-05-29
US9555065B2 (en) 2017-01-31
CN104918640B (zh) 2019-03-19
DK2893045T3 (en) 2018-07-30
LT2893045T (lt) 2018-07-25
ZA201501472B (en) 2016-06-29
US9816150B2 (en) 2017-11-14
IL259652A (en) 2018-07-31
SG10202101556WA (en) 2021-03-30
IL237397B (en) 2018-10-31
US20180023150A1 (en) 2018-01-25
MX2015002792A (es) 2015-05-07
JP6476328B2 (ja) 2019-02-27
US20150231186A1 (en) 2015-08-20
CL2017002826A1 (es) 2018-04-06
MX2018013097A (es) 2020-09-02
EP2893045B1 (en) 2018-05-16
UA118339C2 (uk) 2019-01-10
CN109966511A (zh) 2019-07-05
JP6322326B2 (ja) 2018-05-09
EP2893045A1 (en) 2015-07-15
US10174388B2 (en) 2019-01-08
IL237397A0 (en) 2015-04-30
SI2893045T1 (en) 2018-08-31
WO2014033330A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
PH12015500452B1 (en) A method for selection of agents influencing intestinal motility disorders and pain
WO2013025997A3 (en) Brain stimulation methods for treating central sensitivity
MY194587A (en) Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
WO2011112652A8 (en) Method and device for removing eeg artifacts
EP3876834A4 (en) SYSTEMS AND METHODS FOR COOPERATIVE INVASIVE AND NON-INVASIVE BRAIN STIMULATION
EP4368254A3 (en) Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
MX2016005159A (es) Metodos de diagnostico y tratamiento de trastornos eosinofilicos.
WO2015138795A8 (en) Carotid body ablation with a transvenous ultrasound imaging and ablation catheter
MX2017004547A (es) Sistema de estimulacion nerviosa no invasiva.
MX356933B (es) Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
WO2015195982A3 (en) Baroreceptor mapping system
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
MX2014013676A (es) Uso de moleculas de enlace a la semaforina-4d para promover la neurogenesis despues de la apoplejia.
UY31760A (es) Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de leucotrieno a4 hidrolasa
MX357708B (es) Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
WO2014145432A3 (en) Method for improving cognitive and motor abilities
PH12015502687A1 (en) Marker for acid sphingomyelinase disorders and uses thereof
EP3131459A4 (en) Method and system for muscle pain diagnosis
WO2011106785A3 (en) Methods of identifying agents effective to treat cognitive decline and diseases associated therewith
UA75818U (uk) Спосіб лікування пошкодження нервів верхньої кінцівки на рівні плеча
EP3793669A4 (en) R-R INTERVAL ANALYSIS FOR ECG WAVEFORMS TO ASSESS AUTONOMOUS RESPONSE TO NERVE VAGUE SIMULATION
WO2016112382A3 (en) Intranasal administration of glutamate carboxypeptidase (gcp-ii) inhibitors
UA79243U (ru) Способ диагностики когнитивных нарушений
Dantas et al. Effects of neuromuscular electrical stimulation and resistance training on skeletal muscle responses of elderly people
UA115113U (uk) Спосіб стимуляції блукаючого нерва (n.vagus) для лікування епілепсії